The ESCAIDE Scientific Committee is appointed by the ECDC Director and operates according to the terms of reference
Mike is the Chief Scientist at ECDC. As Head of the Office of the Chief Scientist, he is responsible for driving the scientific agenda and overseeing the quality of the scientific outputs of the Centre. Prior to joining ECDC in 2014, he was the Director of Public Health England’s national Centre for Infectious Disease Surveillance and Control. He is a medical doctor with over 20 years of experience working in infectious disease epidemiology at a national and international levels. His main research interests have been in the fields of sexual health, major incident and disaster response, and medical information systems.
Aura is the Head of the National Coordination Centre for Outbreak Management of the Dutch National Institute for Public Health and Environment and a member of the ECDC Advisory Forum on behalf of EUPHA. Prior to this role, Aura worked for the Delfland Municipal Public Health Service as a physician in social medicine. She is a medical doctor by training, specializing in communicable disease control, with extensive research experience on crisis management in the Netherlands and abroad. Aura holds a PhD in outbreak management from the Radboud University Nijmegen, The Netherlands.
Karl is the Head of the Public Health Capacity and Communication Unit at ECDC. He was the first expert to join the European Centre for Disease Prevention and Control in 2005. Within ECDC, he has been Strategic Adviser to the Director (2005-2007), and Head of the Health Communication Unit (2007-2010). From February to April 2010, Karl was the Centre’s Acting Director. Karl is a medical doctor and a specialist in infectious diseases. He has a PhD in Infectious Diseases from Lund University in Sweden, a Diploma in Tropical Medicine and Hygiene from Prince Mahidol University, Bangkok, Thailand, and a Master's Degree in Epidemiology from the London School of Hygiene and Tropical Medicine. In 1999 he became Associate Professor and in 2007 Adjunct Professor in Infectious Disease Epidemiology, at the Karolinska Institute in Stockholm.
João is currently working as a Researcher in the Molecular Microbiology and Infection Unit at the Instituto de Medicina Molecular in the Faculty of Medicine, University of Lisbon, and teaches at the Instituto Superior Técnico, University of Lisbon. He studied Applied Chemistry, Biotechnology and did his PhD on Microbial typing and data analysis methodologies. João’s research interests are in Bioinformatics and the development of novel analysis and visualization methodologies with special focus on microbiology, molecular epidemiology and microbial typing methods.
Christopher is the Chairman of the Pathology Department at Mater Dei Hospital in Malta. He received his medical training in both Malta and the United Kingdom. Furthermore, he is a Consultant Virologist and Head of the Virology Unit in the Department of Pathology. Christopher also lectures in Microbiology at the University of Malta and is a member of various National Health Committees related to Pathology and Infectious Diseases. He is the National Microbiology Focal Point for Malta at ECDC.
Amrish is the coordinator of the R Epidemics Consortium at Imperial College in London, UK. Here they bring together different stakeholders working in the arena of public health emergencies and outbreak responses to jointly develop new tools, methodologies and training exercises for outbreak analyses using R. He currently still actively participates in international assignments in emergency situations and outbreaks. Having a background in both microbiology and field-epidemiology he undertook his EPIET training in 2015 at Institut Pasteur in Paris, France where he was part of the outbreak investigation taskforce. In 2010 he started his PhD. in close collaboration with the Radboud University, Nijmegen, the Netherlands and the London School of Hygiene and Tropical Medicine, London, UK and the Kenyan Medical Research Institute. Here he looked at patterns of heterogeneity of malaria in an area of Kenya in a large multi-partner project, strongly focussing on involvement of local communities. Before that he worked on fundamental influenza research and completed his MSc. and BSc. degree in biology of infectious diseases at Wageningen University in the Netherlands. He has been the elected president of the board of the EPIET Alumni Network (EAN) since November 2017.
Bojana is a specialist in infectious diseases at the University Medical Centre Ljubljana, Slovenia and a professor of infectious diseases at the Faculty of Medicine, University of Ljubljana. She is the chair of the Slovenian Society for Antimicrobial Chemotherapy and the vice-chair of the National Intersectoral Coordinating Mechanism for Prudent Use of Antimicrobials at the Ministry of Health in Slovenia. She is the chair of ESCMID Study Group for Antimicrobial Stewardship (ESGAP). In the hospital Bojana leads the antimicrobial stewardship programme. She is involved in antimicrobial stewardship education on the national and international level. In the research area she is focused on antimicrobial stewardship and hospital-acquired infections.
Maria Van Kerkhove
Maria Van Kerkhove, PhD is an infectious disease epidemiologist who specialises in outbreaks of emerging and re-emerging pathogens. Dr Van Kerkhove is from the United States and completed her undergraduate degree at Cornell University, a MS Degree at Stanford University, and a PhD in infectious disease epidemiology at the London School of Hygiene and Tropical Medicine. Dr Van Kerkhove is currently the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Technical Lead in the World Health Organization’s Health Emergency Program, in the High Threat Pathogens Unit. Dr Van Kerkhove regularly participates in Missions to affected member states, including the Kingdom of Saudi Arabia, Jordan, Qatar and the Republic of Korea. Prior to WHO, she was the Head of the Outbreak Investigation Task Force at Institut Pasteur’s Center for Global Health where she was responsible for establishing public health rapid response teams for infectious disease outbreaks. Dr Van Kerkhove was previously employed by Imperial College London in the MRC Center for Outbreak Analysis and Modelling where she worked closely with WHO on influenza, yellow fever, meningitis, MERS-CoV and Ebola Virus Disease.